Related references
Note: Only part of the references are listed.Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated
Edmond Atallah et al.
JOURNAL OF HEPATOLOGY (2023)
Busting the myth of methotrexate chronic hepatotoxicity
Vincent Di Martino et al.
NATURE REVIEWS RHEUMATOLOGY (2023)
Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience
Saman Darabian et al.
JOURNAL OF RHEUMATOLOGY (2022)
Review of existing evidence demonstrates that methotrexate does not cause liver fibrosis
Hira Imad Cheema et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2022)
Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis
Ali Azzam et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms
Devaraj Ezhilarasan
TOXICOLOGY (2021)
Adverse Effects of Low-Dose Methotrexate A Randomized Trial
Daniel H. Solomon et al.
ANNALS OF INTERNAL MEDICINE (2020)
Hepatotoxicity related to antirheumatic drugs
Guruprasad P. Aithal
NATURE REVIEWS RHEUMATOLOGY (2011)
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment
Peter Rosenberg et al.
JOURNAL OF HEPATOLOGY (2007)
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
GP Aithal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury
G Langman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)